ISEC Healthcare Ltd. (SGX:40T)
0.330
0.00 (0.00%)
At close: Apr 24, 2026
ISEC Healthcare Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 79.97 | 79.21 | 74.2 | 69.99 | 62.95 | 40.47 | Upgrade
|
| Revenue Growth (YoY) | 6.42% | 6.76% | 6.00% | 11.18% | 55.56% | 11.40% | Upgrade
|
| Cost of Revenue | 46.9 | 45.85 | 41.53 | 38.96 | 34.19 | 22.59 | Upgrade
|
| Gross Profit | 33.08 | 33.36 | 32.67 | 31.04 | 28.77 | 17.88 | Upgrade
|
| Selling, General & Admin | 15.92 | 15.74 | 14.12 | 12.26 | 10.43 | 8.62 | Upgrade
|
| Other Operating Expenses | -0.03 | 0.1 | 0.44 | 0.55 | 1.45 | 0.57 | Upgrade
|
| Operating Expenses | 15.88 | 15.84 | 14.56 | 12.81 | 11.88 | 9.18 | Upgrade
|
| Operating Income | 17.2 | 17.52 | 18.11 | 18.23 | 16.88 | 8.69 | Upgrade
|
| Interest Expense | -0.64 | -0.64 | -0.6 | -0.65 | -0.56 | -0.4 | Upgrade
|
| Interest & Investment Income | 0.36 | 0.36 | 0.33 | 0.3 | - | 0.22 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -0 | -0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | 0.02 | 0.69 | -0.72 | - | -0.13 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.24 | 0.29 | 0.07 | 0.05 | 0.44 | 0.33 | Upgrade
|
| EBT Excluding Unusual Items | 17.17 | 17.55 | 18.6 | 17.19 | 16.77 | 8.7 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -0.05 | Upgrade
|
| Impairment of Goodwill | - | - | -1.52 | - | - | - | Upgrade
|
| Asset Writedown | - | - | -0.01 | -0.01 | - | -0 | Upgrade
|
| Other Unusual Items | 0.16 | 0.16 | 0.12 | 0.13 | 0.01 | 0.44 | Upgrade
|
| Pretax Income | 17.33 | 17.71 | 17.19 | 17.31 | 16.78 | 9.09 | Upgrade
|
| Income Tax Expense | 4.24 | 4.29 | 4.29 | 4.16 | 4.05 | 2.21 | Upgrade
|
| Earnings From Continuing Operations | 13.08 | 13.42 | 12.89 | 13.15 | 12.73 | 6.88 | Upgrade
|
| Minority Interest in Earnings | 0.04 | -0.05 | -0.07 | -0.19 | -0.21 | 0.03 | Upgrade
|
| Net Income | 13.12 | 13.37 | 12.82 | 12.96 | 12.52 | 6.91 | Upgrade
|
| Net Income to Common | 13.12 | 13.37 | 12.82 | 12.96 | 12.52 | 6.91 | Upgrade
|
| Net Income Growth | 2.94% | 4.23% | -1.07% | 3.54% | 81.32% | 47.23% | Upgrade
|
| Shares Outstanding (Basic) | 576 | 576 | 575 | 573 | 564 | 550 | Upgrade
|
| Shares Outstanding (Diluted) | 576 | 576 | 576 | 573 | 564 | 550 | Upgrade
|
| Shares Change (YoY) | 0.09% | 0.02% | 0.38% | 1.73% | 2.42% | 0.52% | Upgrade
|
| EPS (Basic) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| EPS Growth | 2.76% | 4.04% | -1.33% | 1.80% | 77.60% | 45.93% | Upgrade
|
| Free Cash Flow | -3.4 | -0.57 | 5.86 | 13.75 | 12.14 | 11.57 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | 0.01 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Dividend Per Share | - | 0.006 | 0.010 | 0.016 | 0.016 | 0.011 | Upgrade
|
| Dividend Growth | - | -42.00% | -37.89% | 3.21% | 48.57% | 31.25% | Upgrade
|
| Gross Margin | 41.36% | 42.12% | 44.03% | 44.34% | 45.70% | 44.18% | Upgrade
|
| Operating Margin | 21.50% | 22.12% | 24.40% | 26.04% | 26.82% | 21.48% | Upgrade
|
| Profit Margin | 16.40% | 16.88% | 17.28% | 18.52% | 19.89% | 17.06% | Upgrade
|
| Free Cash Flow Margin | -4.25% | -0.73% | 7.90% | 19.65% | 19.28% | 28.58% | Upgrade
|
| EBITDA | 19.67 | 19.93 | 20.28 | 20.22 | 18.58 | 10.31 | Upgrade
|
| EBITDA Margin | 24.60% | 25.16% | 27.33% | 28.89% | 29.52% | 25.48% | Upgrade
|
| D&A For EBITDA | 2.48 | 2.41 | 2.17 | 2 | 1.7 | 1.62 | Upgrade
|
| EBIT | 17.2 | 17.52 | 18.11 | 18.23 | 16.88 | 8.69 | Upgrade
|
| EBIT Margin | 21.50% | 22.12% | 24.40% | 26.04% | 26.82% | 21.48% | Upgrade
|
| Effective Tax Rate | 24.49% | 24.23% | 24.98% | 24.05% | 24.14% | 24.29% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.